<DOC>
	<DOC>NCT00358553</DOC>
	<brief_summary>The purpose of this study is to assess the pharmacokinetics, pharmacodynamics, and safety of recombinant human insulin. The study will consist of 2 phases.</brief_summary>
	<brief_title>A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin</brief_title>
	<detailed_description />
	<mesh_term>Insulin</mesh_term>
	<criteria>Healthy Male Subjects Age between 18 and 40 years of age History of Diabetes Subjects with clinically significant active disease Known allergy to insulin</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Human Volunteers</keyword>
</DOC>